why stop glp 1 before surgery Ozempic, Wegovy usage could be dangerous: doctors π©Ίβ¨ Why You Need to
Description
Exenatide extended-release (Bydureon): This medication is given at a fixed dose of 2 mg subcutaneously once weekly
The July 2024 Harvard study from Massachusetts Eye and Ear found that individuals prescribed Ozempic and other GLP-1 drugs were at a heightened risk for developing NAION

Front Endocrinol (Lausanne) 2021;12:698619

Exenatide formulations show variable nausea rates: the twice-daily immediate-release preparation (Byetta) tends to produce higher rates of nausea (approximately 3050%), whilst the once-weekly extended-release formulation (Bydureon) demonstrates improved tolerability with nausea rates of approximately 1424%, according to their respective SmPCs
20 After 52 weeks, steatohepatitis resolved without fibrosis progression in 44%, 56%, and 62% of participants receiving tirzepatide at doses of 5 mg, 10 mg, and 15 mg, respectively, compared to 10% in the placebo group
